New Real-World Data Show penKid Adding Decision Support for Kidney Replacement Therapy in Critical Care

Data ReadoutpositivepenKidPositive

AI Analysis

Summary

Real-world data from a prospective study of 1,436 critically ill ICU patients demonstrated that penKid (proenkephalin A 119–159) provided clinically relevant information for acute kidney injury severity assessment and kidney replacement therapy management, addressing an unmet need in critical care.

Clinical Trial Data

Primary Endpoint

Met

Patients

1,436

Outcome Details

Real-world study of 1,436 critically ill ICU patients showed penKid provided clinically relevant information across AKI severity and during kidney replacement therapy

Importance:6/10

Sentiment:

0.70

real-world dataacute kidney injurykidney replacement therapycritical careICUdecision support

Related Companies

$WHEN

Read the original article

Published by PR Newswire Pharma on August 27, 2026 8:21 AM

Read Original